Your Vizamyl™ journey begins here

Vizamyl, a PET amyloid imaging agent, is used for detecting amyloid plaques in the brain—a hallmark of Alzheimer's disease (AD).
Full Prescribing Information
At a Glance

Here for your journey

We provide comprehensive Vizamyl and Alzheimer's information in one place.

Vizamyl provides clarity

Establishing amyloid status can help your doctor make important decisions about your healthcare.

Empowering with knowledge

Browse our patient and caregiver resources developed just for you.

Why Vizamyl?

Detecting Alzheimer's disease in its early stages is important for timely interventions and treatment. Vizamyl PET imaging can identify beta amyloid plaques as soon as cognitive symptoms are evident, enabling early detection and intervention.

How does Vizamyl work?

PET is a non-invasive imaging tool that takes pictures like a CT scan. The brain images can then be evaluated for amyloid plaque.

Understanding your diagnosis

Receiving a diagnosis of Alzheimer’s disease is a life-altering moment. Educating yourself about Alzheimer’s disease empowers you to make choices that enhance your overall quality of life.

What is Alzheimer’s disease?

Alzheimer's disease is a progressive and degenerative neurological disorder that primarily affects the brain. It is the most common form of dementia.​

Learn more

What are the Alzheimer’s disease symptoms?

People living with Alzheimer’s may experience common symptoms such as memory loss and cognitive decline.

Learn more
YOUR VIZAMYL JOURNEY

Everything you need to know about the Vizamyl imaging procedure

The procedure spans several hours and is performed by a specially trained healthcare professional. We have provided a comprehensive step-by-step guide to ensure you are well-prepared for this important day. Use the facility locator to find a Vizamyl provider near you.
BEFORE THE EXAM

Follow your doctor’s orders when preparing for this test.

Tell your doctor if you:
  • have any allergies or other medical conditions
  • are pregnant, nursing, or planning to become pregnant
  • have reduced kidney or liver function


    • Always talk with your doctor if you have any questions about Vizamyl PET imaging.
    ON THE DAY OF THE EXAM

    Drink plenty of fluids and wear loose, comfortable clothing.

    On the day of the procedure:
    Drink plenty of fluids and go to the bathroom frequently before your Vizamyl PET imaging and for 1 day afterward
    Wear loose, comfortable clothing, because you will have to lie still for a period of time
    Ask a family member/guardian to join you if you need the support
    DURING THE EXAM

    During the imaging test, you will need to lie very still.

    What to expect during the test
    Vizamyl will be injected through an intravenous line in your arm
    You will need to wait 1-2 hours after the injection for the imaging test while your body absorbs Vizamyl
    You will be asked to lie on a table and positioned on a head support. A strip of tape may be placed across your forehead or chin to minimize head movement
    You must try to remain as still as possible (~20 minutes)
    AFTER THE EXAM

    Your doctor will explain the test results and what they mean for your treatment options.

    You can continue with your regular activities (unless your doctor tells you otherwise)
    Drink plenty of fluids and use the bathroom frequently

    Test Results:
    Depending on the results of your test, your doctor will discuss what this means and provide comprehensive guidance.
    CHECKLIST

    Important things to remember

    Dress appropriately

    Wear loose, comfortable clothing.

    Fluids and voiding

    Drink fluids and go to the bathroom frequently before your test and for 1 day afterward.

    Questions

    Call your doctor if you have any questions or concerns about Vizamyl imaging.

    Loved one

    Ask a family member or guardian to accompany you if you need the support.

    Have a question? Contact your Health Care Provider.

    Important Safety Information

    Vizamyl — Important Safety Information for Consumers


    Product Use

    VIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:
    • Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline
    • Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.

    Important Safety Information About Vizamyl (flutemetamol F 18 injection)

    You should not be given Vizamyl if: You have a history of hypersensitivity reaction to Vizamyl or polysorbate 80. Your healthcare professional (HCP) can help you understand what the drug ingredients are.

    What is the most important information you should know about Vizamyl?

    • Allergies: Tell your HCP if you are allergic to any medications or a substance called polysorbate 80.
    • Reactions such as flushing and shortness of breath have been seen within minutes following administration of Vizamyl. Postmarketing experience included anaphylactic reactions.
    • Radiation Risk: Vizamyl contributes to your long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. Please be well hydrated and urinate regularly after your test.

    The most common side effects of Vizamyl include:

    Flushing, increased blood pressure, headache, nausea and dizziness. Instruct patients to inform their healthcare provider if they:
    • have had prior reactions to Vizamyl or any component, including polysorbate 80, or
    • have reduced renal or hepatic function
    Instruct patients to increase their level of hydration before and after receiving Vizamyl (flutemetamol F 18 injection) and to void frequently following Vizamyl administration.

    Make sure you tell your HCP:

    • All the medications you are taking, including any over-the-counter medications.
    • If you are pregnant, may be pregnant or plan to become pregnant.
    • If you are breastfeeding.

    Children and Elderly:

    • Vizamyl should not be used in those less than 18 years old.
    • Studies showed no difference in safety between those over 65 years old and those between 18 and 65 years old.

    The safety information included here is not comprehensive. If you have any questions, please be sure to discuss them with your HCP.


    Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information.


    For more information about Vizamyl, call GE HealthCare Customer Service at (800) 292-8514.

    To report SUSPECTED ADVERSE REACTIONS, contact GE HealthCare at 800 654 0118 (option 2 then option 1) or by email at GPV.drugsafety@gehealthcare.com or FDA at 800 FDA 1088 or www.fda.gov/medwatch.

    Please see the full Prescribing Information for Vizamyl HERE.

    JB08977US